Completed PHASE3 INTERVENTIONAL 2-arm NCT01147926

Evaluation of Prucalopride in Male Subjects With Chronic Constipation.

A 12-week, Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Quality of Life, Safety and Tolerability of Prucalopride in Male Subjects With Chronic Constipation

Sponsor: Shire

Conditions Male Subjects With Chronic Constipation

Interventions Placebo Prucalopride

Updated 7 times since 2017 Last updated: May 26, 2021 Started: Sep 23, 2010 Primary completion: Oct 25, 2013 Completion: Oct 25, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Male Subjects With Chronic Constipation and is currently completed. Shire leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Sep 2021 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Sep 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shire

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Amersfoort, Netherlands , Amiens, France , Amsterdam, Netherlands , Angers, France , Antwerp, Belgium , Avrillé, France , Ballerup Municipality, Denmark , Bath, United Kingdom , Beek, Netherlands and 49 more locations